Reducing glucose fluctuation is important for patients with chronic conditions, such as diabetes, cardiovascular diseases, and obesity, because decreased glycaemic excursions are beneficial for improving insulin sensitivity, oxidative stress, and endothelial dysfunction [32, 33]. The gene discussed is INS; the disease is Obesity.